HIGHFDA DRUG

Cipla USA Recalls Cinacalcet Hydrochloride Tablets Over Nitrosamine Hazard

Cipla USA, Inc. recalled 15,744 bottles of Cinacalcet Hydrochloride Tablets on November 14, 2025. The recall follows the discovery of a nitrosamine impurity exceeding acceptable daily intake limits. Consumers should stop using the product immediately and consult healthcare providers.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
November 14, 2025
Status
ACTIVE
Severity
7/10

Quick Facts at a Glance

Recall Date
November 14, 2025
Hazard Level
HIGH
Brands
CINACALCET, Cipla USA Inc.
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
CINACALCET, Cipla USA Inc.
Product type
Cinacalcet Hydrochloride Tablets
Model numbers
Lot 5PB0164, exp 1/31/2027
UPC codes
69097-410, 69097-411, 69097-412, 69097-410-02, 69097-411-02, 69097-412-02
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    November 14, 2025

  2. Reported by FDA DRUG

    December 17, 2025

  3. RecallRadar source check

    December 24, 2025

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Cipla USA, Inc. or your healthcare provider for guidance. Notification method: Letter

About This Product

Cinacalcet Hydrochloride Tablets are prescribed for managing conditions related to parathyroid hormone levels, particularly in patients with chronic kidney disease. They help regulate calcium levels in the body, making them essential for certain patients.

Why This Is Dangerous

The presence of N-nitroso-cinacalcet in the tablets poses a health risk as it exceeds acceptable daily intake limits. This impurity can lead to serious health consequences if consumed regularly.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Consumers may face health risks associated with the impurity in the recalled tablets. The urgency to stop use and seek alternatives may lead to disruptions in treatment for some patients.

Practical Guidance

How to identify if yours is affected

  1. Locate the lot number on your bottle of Cinacalcet Hydrochloride Tablets.
  2. Check if it matches Lot 5PB0164.
  3. Confirm the expiration date is January 31, 2027.

Where to find product info

The lot number and expiration date can typically be found on the label or bottom of the bottle.

What timeline to expect

Expect a refund or further instructions within 4-6 weeks following the recall notification.

If the manufacturer is unresponsive

  • Contact Cipla USA, Inc. directly via phone or email.
  • Document all correspondence regarding the recall.

How to prevent similar issues

  • Always check for recent recalls on medications before use.
  • Consult your healthcare provider about alternatives if a recall occurs.

Documentation advice

Keep receipts, correspondence with the manufacturer, and any medical records related to your use of the affected product.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

The recall involves Cinacalcet Hydrochloride Tablets, 60 mg, sold in 30-tablet bottles. The affected lot is Lot 5PB0164, which has an expiration date of January 31, 2027. The product was distributed nationwide in the United States.

Key Facts

  • Recall date: November 14, 2025
  • Quantity recalled: 15,744 bottles
  • Affected lot: Lot 5PB0164
  • Expiration date: January 31, 2027
  • Hazard: Nitrosamine impurity present

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
7/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
Lot 5PB0164
exp 1/31/2027
UPC Codes
69097-410
69097-411
69097-412
+3 more
Affected States
ALL
Report Date
December 17, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
HIGH

Cipla USA Recalls Lanthanum Carbonate Tablets Over Stability Issues

Cipla USA recalled 1,180 boxes of Lanthanum Carbonate chewable tablets on October 24, 2025. The recall follows a failure to meet stability specifications for hardness tests. Consumers and healthcare providers must stop using the product immediately.

LANTHANUM CARBONATE
Failed stability
Read more